HAWKINS JAMES B has demonstrated a mixed but notable pattern of insider trading activity across three companies—AEYE, OSIS, and IRMD—with a clear tilt toward selling in aggregate dollar terms. Over the course of 40 reported transactions, total sales amounted to $2.4 million, significantly outweighing purchases of $1.07 million. However, recent activity suggests a shift toward accumulation, particularly in AEYE, where Hawkins executed a series of purchases totaling $219,700 between March 10 and March 12, 2026, including transactions of $82,713, $74,999, and $62,031. This follows earlier buys in November 2025, with multiple purchases in the $22,000–$100,600 range.
In contrast, Hawkins has been a consistent seller of IRMD and OSIS shares. The largest single sale occurred on December 9, 2025, when $289,837 worth of IRMD stock was disposed of, followed by multiple smaller IRMD sales in November 2025 totaling over $164,000. OSIS saw a significant sale of $424,725 on November 7, 2025, though earlier in August 2025, Hawkins acquired $199,934 in OSIS shares via an award. The data suggests a strategic divergence: while reducing exposure to IRMD and OSIS, Hawkins has steadily increased holdings in AEYE, particularly in recent months. The absence of any sales in AEYE, coupled with repeated purchases, indicates a concentrated accumulation in that position.
AI-assisted summary